Cato Laurencin

Cato Laurencin

Director/Board Member presso ALKERMES PLC

Patrimonio netto: 2 M $ in data 29/02/2024

65 anni
Consumer Services
Commercial Services
Health Technology

Profilo

Cato T.
Laurencin
founded W Montague Cobb, Biorez, Inc. and Natural Polymer Devices, Inc. Dr. Laurencin is President, CEO, Secretary & Director at Natural Polymer Devices, Inc., Chief Executive Officer at Connecticut Institute For Clinical & Translational Science and Chief Executive Officer of The Cato T Laurencin Institute For Regenerative Engineering.
He is also on the board of American Institute of Chemical Engineers, MiMedx Group, Inc. and Alkermes Plc and Professor at the University of Connecticut, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Engineering, Member of National Academy of Medicine (United States) and Chief Editor at Springer Nature Switzerland AG.
In his past career Dr. Laurencin held the position of Chief Resident-Orthopedic Surgery at Beth Israel Hospital, Chairman-Orthopedic Surgery & Professor at the University of Virginia, Vice President-Health Affairs at the University of Connecticut Health Center, Professor at Drexel University College of Medicine and Dean at The University of Connecticut School of Medicine.
Dr. Laurencin received an undergraduate degree from Princeton University, a doctorate from Massachusetts Institute of Technology and a doctorate from Harvard Medical School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
13/06/2023 130 124 ( 0.11% ) 1 M $ 29/02/2024
15/02/2024 15 169 ( 0.01% ) 450 368 $ 29/02/2024

Posizioni attive di Cato Laurencin

SocietàPosizioneInizio
MIMEDX GROUP, INC. Director/Board Member -
ALKERMES PLC Director/Board Member 18/11/2021
Founder 17/06/2011
Springer Nature Switzerland AG Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
University of Connecticut Corporate Officer/Principal 01/01/2008
Director/Board Member 29/10/2018
Connecticut Institute For Clinical & Translational Science Chief Executive Officer -
Tutte le posizioni attive di Cato Laurencin

Precedenti posizioni note di Cato Laurencin

SocietàPosizioneFine
░ ░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░ ░░░░░░░ -
Vedi nel dettaglio l'esperienza di Cato Laurencin

Formazione di Cato Laurencin

Massachusetts Institute of Technology Doctorate Degree
Princeton University Undergraduate Degree
Harvard Medical School Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Cato Laurencin

Relazioni

100 +

Relazioni di 1° grado

23

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
MIMEDX GROUP, INC.

Health Technology

ALKERMES PLC

Health Technology

Aziende private13

Health Technology

Health Technology

Electronic Technology

Health Services

Health Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Connecticut Institute For Clinical & Translational Science

Springer Nature Switzerland AG

W Montague Cobb/Nma Health Institute

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Cato Laurencin